Summary:
In adults with type 2 diabetes and comorbid insomnia, remotely-delivered cognitive behavioral therapy for insomnia (CBTI) significantly improved sleep regularity and reduced anxiety, alongside lowering fasting glucose levels compared to usual care or no CBTI intervention, though it was associated with variability in adherence and no significant adverse effects reported.
| PICO | Description |
|---|---|
| Population | Adults diagnosed with type 2 diabetes mellitus experiencing clinical insomnia. |
| Intervention | Remotely-delivered cognitive behavioral therapy for insomnia (CBTI), delivered via digital platforms, targeting sleep hygiene and cognitive restructuring. |
| Comparison | Usual care without targeted insomnia treatment or waitlist control conditions. |
| Outcome | Significant improvements in sleep regularity and reductions in anxiety symptoms were observed in the CBTI group. Additionally, fasting glucose levels decreased, indicating ancillary benefits to glycemic control. No major adverse events reported; adherence influenced effectiveness. |
Source: Kirisri, Similan, et al. “Effects of remotely-delivered cognitive behavioral therapy for insomnia in type 2 diabetes: a randomized controlled trial.” Read article here.
